Sobhan Oncology Pharmaceutical Company (DSANKO)
- Ticker
- DSANKO
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Line of business
Research, development, advancement and manufacture of pharmaceutical and/or chemical products directly or through third parties; production, purchase, exchange, import, sale, distribution, export, marketing and trade in any way in products including oncology products, biological products, health sector products, medical and laboratory equipment, food and pharmaceutical supplements, and pharmaceutical and chemical goods and merchandise.
Latest trading day
Date: October 25, 2026
- Closing price
- 3,850 rials
- Change on the previous close
- +0.52%
- Volume
- 50,766,859 shares
- Trade value
- 19.54 billion tomans
- Market cap
- 2,310 billion tomans
DSANKO returns against the market, the dollar and gold
Up to the stock's last trade on October 25, 2026. Each row runs from the last price before the period starts to the latest price, and the stock's return is adjusted for capital raises and cash dividends. The indexes come from the Tehran Stock Exchange (TSETMC); the free-market dollar and 18k gold are daily free-market prices in tomans.
| Series | 1 month |
|---|---|
| DSANKO | 14.9% |
| Bourse total index | 10.8% |
| Farabourse total index | 16.4% |
| Free-market dollar | 15.2% |
| 18k gold (per gram) | 7.5% |
Weekly, 3-month, 1-year and 5-year returns, and the comparison with the industry, the Emami gold coin, the world gold ounce and Tehran housing, are on Fundai with free sign-up.
Key figures
| Item | Value | Basis |
|---|---|---|
| P/E TTM | 65.25 | Report to 1405/06/31 |
| P/B | 3.58 | Report to 1405/06/31 |
| Gross margin TTM | 66.2% | Report to 1405/06/31 |
| Net margin TTM | 2.9% | Report to 1405/06/31 |
| ROE TTM | 5.5% | Report to 1405/06/31 |